Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Bictegravir in Renal Impairment
NCT02400307Phase 1Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of bictegravir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Gilead Sciences. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity (Total Bictegravir) at Day 1, Area Under the Concentration-Time Curve from Time Zero to Infinity (Free Bictegravir) at Day 1 and 4 more. Started Apr 2015; status: completed.
02
Drugs
bictegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02400307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400307.